Conditions treated with antipsychotic medication, including psychosis, schizophrenia, schizoaffective disorder and affective disorder with psychotic symptoms Mental and Behavioural Disorders Psychosis
Conditions
Interventions
Care coordinators (with all their allocated participants) will be randomised to either using the Medication Review Form or continue with treatment as usual.
1. Using the Medication Re
Sponsors
North East London NHS Foundation Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Over 18 years 2. Currently taking antipsychotic medication 3. Have a diagnosis of psychosis, schizophrenia, schizoaffective disorder or affective disorder with psychotic symptoms
Exclusion criteria
Exclusion criteria: Non-English speakers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decision Self-Efficacy Scale, which is a brief 11 item questionnaire that assesses service users? confidence in participating in medication-related discussions and decisions | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Drug Attitude Inventory 10 item scale (DAI) 2. Brief Positive and Negative Syndrome Scale (PANSS) consisting 7 subscales 3. Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) Questionnaire 4. Medication Adherence Questionnaire 5. Tablets Routine Questionnaire 6. Changes in Medication 7. Qualitative data on service users experiences of using the Medication Review Tool Feedback from prescribers and care coordinators: The Service Engagement Subscale will be administered over the telephone in brief telephone interviews with care coordinators involved in the study. An adapted version of the Physician Satisfaction Questionnaire (PSQ) will be administered with psychiatrists involved in the study. Qualitative feedback on the use of the Medication Review Tool will also be obtained from psychiatrists and care coordinators. | — |
Countries
United Kingdom
Outcome results
None listed